The Nasdaq 100 faces short-term downside because a failed push to a new high leaves crowded bullish sentiment vulnerable to a break below. Despite record institutional accumulation and a long-term bullish position, five months of chop, a failed ATH and an attempted loss of the bullish trend favor hedging rather than adding leverage. x.com  x.com 

Nasdaq-100 trackers are about to be forced buyers of SpaceX at the worst price, funded by selling the index's best businesses. Around July 6, about 15 trading days after its IPO, SpaceX joins the Nasdaq-100 under rewritten rules that scrapped the float requirement. Cuts are proportional to weight, so Apple, Microsoft and Nvidia get trimmed hardest to buy a company losing $4 billion a quarter, near 100 times sales after a run from $135 toward $200. The S&P 500 kept its profitability rule. x.com  … Show more

SpaceX looks set to rise before its July 7 Nasdaq-100 inclusion, as passive index buying, a low float and options-driven gamma squeezes power the stock. CRSP, FTSE Russell and MSCI inclusions also force buying regardless of valuation; above $225 it could reach $300, about $4 trillion. After that, the stance turns bearish: as lockups expire and the float grows from about 5%, early investors' selling should overwhelm buying for a loss-making company, so long-term buyers could wait a year. x.com  … Show more

SpaceX faces a series of large share unlocks that could add selling supply. Another 911 million shares become eligible for sale tomorrow, followed by 328 million on Oct. 24, 319 million on Oct. 26, 1.3 billion in early November and 797 million in December; Elon's 6.4 billion shares become eligible in June 2027. x.com 

SpaceX looks set up for a big 2027 as its stock has handled earlier share unlocks well and the lockup schedule winds down. About 798 million shares become eligible for sale after the December 8 close; the June 2027 block is Musk's, and he is not selling. Other extended-investor tranches continue through 2027. x.com 

US tech stocks face a short-term liquidity drain as institutions sell existing tech and AI hardware holdings to fund the SpaceX IPO on June 12. The deal will pull $75B-$85B of cash from the market, and funds must back their orders with capital by Thursday night. An early-week dead-cat bounce could give way to peak drain midweek, after which over-allocated or unused cash should flow back into tech. Macro data or a rogue headline could easily send markets the opposite way. x.com 

SpaceX faces near-term selling risk from an insider-share unlock despite a remarkably strong quarter. Tomorrow, 28% of its insider lockup pool, nearly 10% of all shares, becomes eligible for sale. Revenue reached $14.6 billion, up 161%, with $4.4 billion in net profit; $7.6 billion in AI revenue now exceeds Starlink and other connectivity revenue combined. x.com 

Nasdaq index funds will be required to buy SpaceX at market around July 6, and they will have to sell existing holdings to do it. That forced buying should likely lift SpaceX, while the selling puts downward pressure on familiar Nasdaq 100 tech names, which face significant outflows. Anyone buying tech should wait until after that date. x.com 

SpaceX's Nasdaq inclusion before the July 7 open, one of the fastest ever after an IPO, should bring over $4.5 billion of estimated passive buying from index funds that must buy regardless of price. It follows a Palantir-like post-IPO shakeout from $150 to $215 and back to $165, with $145-165 seen as an accumulation zone and the target still $250+. x.com 

SpaceX's unlock selling should clear by Monday, perhaps tomorrow, allowing a rally. If 200M of nearly 2B unlocked shares sell, 100M daily volume versus a 70M baseline takes seven to eight days to absorb them; $150 cannot break until then. Turnover since the 1.3B unlock should hit 700M tomorrow. Insanely bullish earnings and a super-low-risk bet on massive Q4 cash flows and the exceptional 2027 outlook make SpaceX the #1 rally pick once market tantrums end. x.com  x.com